Angiopoietin-Like4 is Associated with Lipid Metabolism and Severe Fibrosis in Non-Diabetic Patients with Non-Alcoholic Fatty Liver Disease
Chiara Rosso(University of Turin), Elisabetta Bugianesi(University of Turin), M.L. Abate(University of Turin), M. Marietti(University of Turin), Chiara Saponaro(University of Pisa), Federica Carli(Istituto di Fisiologia Clinica), G.P. Caviglia(University of Turin), A. Smedile(University of Turin), Amalia Gastaldelli(National Research Council), E. Buzzigoli(Istituto di Fisiologia Clinica), G.M. Saracco(University of Turin), Melania Gaggini(Istituto di Fisiologia Clinica)
Cited by 3
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k